Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Unknown 10Terminated 4Completed 3

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 2Gastrointestinal 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Solid Tumors 1Rectal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × INDUSTRY × tesetaxel × Clear all
NCT01170975 2012-07-24

Effects of Food on the Pharmacokinetics of Tesetaxel 10 mg Capsules

Genta Incorporated

Phase 1 Completed
12 enrolled
Other solid neoplasm

Solid Tumors

NCT00077077 2012-05-16

DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Daiichi Sankyo

Phase 1 Completed
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00080834 2012-05-16

DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma

Daiichi Sankyo

Phase 2 Completed
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡